2015 | Laboratorio Reig Jofre

18 December 2015

Changes in the Board of Directors

17 November 2015

Treasury stock transactions 9M 2015

11 November 2015

Appointment of Frederic Dingeon as head of the antibiotics development and production business unit

3 November 2015

Results note: Third quarter 2015

30 October 2015

Reorganization of the delegated committees

15 October 2015

Reig Jofre starts national and international presentation roadshow

22 September 2015

Execution of the cancellation and consolidation of shares (reverse split)

17 September 2015

Reig Jofre will lead the marketing development in Europe of a nutritional supplement against tuberculosis

15 September 2015

Clarification on the reverse split date

25 August 2015

Resignation of Natra from the board of directors

17 August 2015

Treasury stock transactions 6M 2015

31 July 2015

Implementation procedures of the reverse split

30 July 2015

Reig Jofre releases the documentation of the conference presentation on 2015 first half results

30 July 2015

Results outline on the first half of 2015

27 July 2015

Cofides supports Reig Jofre international development

20 July 2015

Reig Jofre announces conference on the six-month 2015 results

22 June 2015

Reig Jofre will conclude the reverse split in September

12 June 2015

Resolutions on the general shareholders’ meeting

18 May 2015

Treasury stock operations 3M 2015

11 May 2015

Convening of General Shareholders’ Meeting 2015